The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells

References

• Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355:51 - 65; PMID: 16822996; http://dx.doi.org/10.1056/NEJMra052166
   PubMed Web of Science ®Google Scholar
• Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975–2007 Bethesda, MD National Cancer Institute http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site 2010
   Google Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949 - 954; PMID: 12068308; http://dx.doi.org/10.1038/nature00766
   PubMed Web of Science ®Google Scholar
• Corcoran RB, Settleman J, Engelman JA. Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancers. Oncotarget 2011; 2:336 - 346; PMID: 21505228
   PubMed Web of Science ®Google Scholar
• Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol 2011; 29:1239 - 1246; PMID: 21343559; http://dx.doi.org/10.1200/JCO.2010.32.4327
   PubMed Web of Science ®Google Scholar
• Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363:809 - 819; PMID: 20818844; http://dx.doi.org/10.1056/NEJMoa1002011
   PubMed Web of Science ®Google Scholar
• Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 2010; 467:596 - 599; PMID: 20823850; http://dx.doi.org/10.1038/nature09454
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683 - 692; PMID: 17320506; http://dx.doi.org/10.1016/j.cell.2007.01.029
   PubMed Web of Science ®Google Scholar
• McCabe MT, Brandes JC, Vertino PM. Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res 2009; 15:3927 - 3937; PMID: 19509173; http://dx.doi.org/10.1158/1078-0432.CCR-08-2784
   PubMed Web of Science ®Google Scholar
• Rothhammer T, Bosserhoff AK. Epigenetic events in malignant melanoma. Pigment Cell Res 2007; 20:92 - 111; PMID: 17371436; http://dx.doi.org/10.1111/j.1600-0749.2007.00367.x
   PubMedGoogle Scholar
• Estécio MR, Yan PS, Ibrahim AE, Tellez CS, Shen L, Huang TH, et al. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res 2007; 17:1529 - 1536; PMID: 17785535; http://dx.doi.org/10.1101/gr.6417007
   PubMed Web of Science ®Google Scholar
• Hou P, Liu D, Xing M. Genome-wide alterations in gene methylation by the BRAFV600E mutation in papillary thyroid cancer cells. Endocr Relat Cancer 2011; 18:687 - 697; PMID: 21937738; http://dx.doi.org/10.1530/ERC-11-0212
   PubMed Web of Science ®Google Scholar
• Xing M. Gene methylation in thyroid tumorigenesis. Endocrinology 2007; 148:948 - 953; PMID: 16946009; http://dx.doi.org/10.1210/en.2006-0927
   PubMed Web of Science ®Google Scholar
• Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53:1137 - 1144; PMID: 15247181; http://dx.doi.org/10.1136/gut.2003.037671
   PubMed Web of Science ®Google Scholar
• Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38:787 - 793; PMID: 16804544; http://dx.doi.org/10.1038/ng1834
   PubMed Web of Science ®Google Scholar
• Nagasaka T, Koi M, Kloor M, Gebert J, Vilkin A, Nishida N, et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 2008; 134:1950 - 1960; PMID: 18435933; http://dx.doi.org/10.1053/j.gastro.2008.02.094
   PubMed Web of Science ®Google Scholar
• Ang PW, Li WQ, Soong R, Iacopetta B. BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients. Cancer Lett 2009; 273:221 - 224; PMID: 18778891; http://dx.doi.org/10.1016/j.canlet.2008.08.001
   PubMed Web of Science ®Google Scholar
• Shalev SA, Chervinski E, Weiner E, Mazor G, Friez MJ, Schwartz CE. Clinical variation of Aarskog syndrome in a large family with 2189delA in the FGD1 gene. Am J Med Genet A 2006; 140:162 - 165; PMID: 16353258
   PubMed Web of Science ®Google Scholar
• Whitehead IP, Abe K, Gorski JL, Der CJ. CDC42 and FGD1 cause distinct signaling and transforming activities. Mol Cell Biol 1998; 18:4689 - 4697; PMID: 9671479
   PubMed Web of Science ®Google Scholar
• Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta 2007; 375:36 - 42; PMID: 16979611; http://dx.doi.org/10.1016/j.cca.2006.07.019
   PubMed Web of Science ®Google Scholar
• Hoeflich KP, Eby MT, Forrest WF, Gray DC, Tien JY, Stern HM, et al. Regulation of ERK3/MAPK6 expression by BRAF. Int J Oncol 2006; 29:839 - 849; PMID: 16964379
   PubMed Web of Science ®Google Scholar
• Maddodi N, Bhat KM, Devi S, Zhang SC, Setaluri V. Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and downregulation of transcription repressor HES1. J Biol Chem 2010; 285:242 - 254; PMID: 19880519; http://dx.doi.org/10.1074/jbc.M109.068668
   PubMed Web of Science ®Google Scholar
• Sassa M, Hayashi Y, Watanabe R, Kikumori T, Imai T, Kurebayashi J, et al. Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer. Thyroid 2011; 21:511 - 517; PMID: 21449767; http://dx.doi.org/10.1089/thy.2010.0295
   PubMed Web of Science ®Google Scholar
• MacLeod AR, Rouleau J, Szyf M. Regulation of DNA methylation by the Ras signaling pathway. J Biol Chem 1995; 270:11327 - 11337; PMID: 7744770; http://dx.doi.org/10.1074/jbc.270.19.11327
   PubMed Web of Science ®Google Scholar
• Deng C, Yang J, Scott J, Hanash S, Richardson BC. Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem 1998; 379:1113 - 1120; PMID: 9792444; http://dx.doi.org/10.1515/bchm.1998.379.8-9.1113
   PubMed Web of Science ®Google Scholar
• Bigey P, Ramchandani S, Theberge J, Araujo FD, Szyf M. Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. Gene 2000; 242:407 - 418; PMID: 10721735; http://dx.doi.org/10.1016/S0378-1119(99)00501-6
   PubMed Web of Science ®Google Scholar
• Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001; 44:397 - 407; PMID: 11229472; http://dx.doi.org/10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.0.CO;2-N
   PubMed Web of Science ®Google Scholar
• Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, et al. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 2005; 280:23363 - 23370; PMID: 15831492; http://dx.doi.org/10.1074/jbc.M503083200
   PubMed Web of Science ®Google Scholar
• Gazin C, Wajapeyee N, Gobeil S, Virbasius CM, Green MR. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007; 449:1073 - 1077; PMID: 17960246; http://dx.doi.org/10.1038/nature06251
   PubMed Web of Science ®Google Scholar
• Lu R, Wang X, Chen ZF, Sun DF, Tian XQ, Fang JY. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J Biol Chem 2007; 282:12249 - 12259; PMID: 17307743; http://dx.doi.org/10.1074/jbc.M608525200
   PubMed Web of Science ®Google Scholar
• Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008; 647:21 - 29; PMID: 18723033; http://dx.doi.org/10.1016/j.mrfmmm.2008.07.010
   PubMed Web of Science ®Google Scholar
• Smits M, Nilsson J, Mir SE, van der Stoop PM, Hulleman E, Niers JM, et al. miR-101 is downregulated in glioblastoma resulting in EZH2-induced proliferation, migration and angiogenesis. Oncotarget 2010; 1:710 - 720; PMID: 21321380
   PubMed Web of Science ®Google Scholar
• Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, et al. Genetic alterations and their relationship in the phosphatidylinositol-3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 2007; 13:1161 - 1170; PMID: 17317825; http://dx.doi.org/10.1158/1078-0432.CCR-06-1125
   PubMed Web of Science ®Google Scholar
• Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59:2307 - 2312; PMID: 10344734
   PubMed Web of Science ®Google Scholar
• Heisler LE, Torti D, Boutros PC, Watson J, Chan C, Winegarden N, et al. CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res 2005; 33:2952 - 2961; PMID: 15911630; http://dx.doi.org/10.1093/nar/gki582
   PubMed Web of Science ®Google Scholar
• Yan PS, Chen CM, Shi H, Rahmatpanah F, Wei SH, Caldwell CW, et al. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 2001; 61:8375 - 8380; PMID: 11731411
   PubMed Web of Science ®Google Scholar
• Shi H, Yan PS, Chen CM, Rahmatpanah F, Lofton-Day C, Caldwell CW, et al. Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res 2002; 62:3214 - 3220; PMID: 12036936
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402 - 408; PMID: 11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Hou P, Ji M, Xing M. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol-3-kinase/AKT signaling pathway in thyroid tumors. Cancer 2008; 113:2440 - 2447; PMID: 18831514; http://dx.doi.org/10.1002/cncr.23869
   PubMed Web of Science ®Google Scholar
• Hattermann K, Mehdorn HM, Mentlein R, Schultka S, Held-Feindt J. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Anal Biochem 2008; 377:62 - 71; PMID: 18384736; http://dx.doi.org/10.1016/j.ab.2008.03.014
   PubMed Web of Science ®Google Scholar
• Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y, et al. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer 2006; 119:2322 - 2329; PMID: 16858683; http://dx.doi.org/10.1002/ijc.22110
   PubMed Web of Science ®Google Scholar